Search results for: Health Policy and Regulation
Filter search results
Universal Health Coverage: The Holy Grail?
1 January 2015
…available to the entire population free of charge, and providing the best health advice and treatment, was the foundation stone for the creation of the National Health Service. The health…
A Doctor Looks at Health Economics
1 March 1994
…determining health, how healthcare should be financed and organised to minimise inequality and the role that cost-effectiveness analysis and public consultation can play in taking difficult decisions about rationing healthcare….
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…and Summer this year. At the ISPOR International Annual conference, held May 8th – 10th in Boston, health policy stakeholders came together to discuss the IRA and speculate on the…
Driving Green Change: Lessons from the 2024 Innovation Policy Prize
5 February 2025
…global solutions for the most pressing health economic policy challenges of the day. The Innovation Policy Prize is open to entries from a wide range of professions and levels of…
Can the US Afford to Ignore Cost-Effectiveness Evidence in Health Care?
23 July 2013, 11:00pm
…of aggregate health gains and cost-savings. Lastly, he discussed the challenges associated with incorporating cost-effectiveness evidence into coverage policy, including implications of the 2010 US health care reform legislation. James D…
The New NHS: What Can We Learn From Managed Care in New Zealand and the US?
1 July 1999
…measures of quality of outcome and patient experiences. • New Zealand and the US can also learn from the UK. For example, the development of Health Action Zones and long-term…
Anita Charlesworth
18 January 2023
…Council and Economic and Social Research Council (ESRC). Anita is fellow and member of the Council of the Royal Economic Society and University of Bath, Institute for Policy Research Advisory…
As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?
26 September 2018
…pay for TB drugs and diagnostics out of government coffers. For BRICS, maintenance of the status quo—with subpar treatment options and growing drug resistance—implies an ever-expanding health and fiscal burden…
Professor Lotte Steuten Appointed OHE Vice President and Head of Consulting
8 January 2019
…treatment options. Her research expertise is in the fields of health economics and health services research. She specializes in developing and applying quantitative methods for estimating and comparing the expected…